Turning the Tide: Gilead Sciences’ Person-Centered Approach in HIV

A message from our partner [New Scientist logo] [Gilead logo] Every now and then, New Scientist helps a carefully selected commercial partner speak to our audience. Their support helps us produce the high quality journalism we bring you every week. We hope you find today's message relevant and useful.   [New Scientist Colab Presents: Integrating Scientific Innovation and Health Equity. Links to podcast]( [New Scientist Colab Presents: Integrating Scientific Innovation and Health Equity. Links to podcast]( The Impact of Person-Centered Collaboration in Advancing HIV Research and Health Equity The scientific community has made tremendous toward ending the HIV epidemic, developing biomedical innovations that have helped transform HIV into a treatable chronic condition for millions of people and also one that can be prevented. Nevertheless, HIV persists as a serious public health challenge. More Than Medicine to Overcome the HIV Epidemic To end the HIV epidemic, it is essential to extend beyond a biomedical approach and to fully integrate social determinants of health into the collective response. Key player Gilead is committed to advancing person-centered science and actionable education programs that make a difference for individuals and communities affected by HIV. Jared Baeten, head of HIV R&D at Gilead, discusses this [here](. In partnership with Gilead Sciences. Jared discusses the latest advances in HIV research and Gilead's collaborative efforts to forge a more equitable and innovative HIV response. [Listen for free](   [Facebook]( [Twitter]( [Instagram]( [LinkedIn]( [TikTok]( [WhatsApp]( [Update preferences]( | [Help]( | [Contact us]( [View in browser]( This email has been sent to {EMAIL}. [Unsubscribe]( from further emails relating to selected third party partners from New Scientist. Do not reply directly to this email. If you have an enquiry, please contact us using the relevant contact details [listed here](. Copyright © New Scientist Ltd Registered Office: Northcliffe House, 2 Derry Street, London, W8 5TT Registered in England. No.10644366 Australian mailing address: PO Box 2315, Strawberry Hills, NSW 2012, Australia Registered in Australia. ABN 22 621 413 170 [Privacy Policy]( | [Terms & Conditions](